Ode Pharma
Ode Pharma – Lung Medicine to Japan
![](https://kin-japan.net/wp-content/uploads/2022/08/7.jpg)
Problem / difficulty
A long process and high budget to go the path of licensing a drug in Japan involving clinical trials in most cases.
challenge
Choosing the right path, with the right partners, to work parallel to get the certification needed during the pandemic.
![](https://kin-japan.net/wp-content/uploads/2022/08/photo_2022-08-24_22-49-29.jpg)
solution
Extensive research led to steps such as converting food additives while working on medical procedures. We found that the product ingredient was on the Ministry of Health’s safe list; therefore, we could complete the clinical trial while distributing the product as a food additive. Because the additive was on the safe list, we were able to support a trial of 180,000 supplement doses – 3000 employees with 60 pills each.
![](https://kin-japan.net/wp-content/uploads/2022/08/12-1.jpg)
other Case studies
SERVICES
© 2024K.I.N Co.,Ltd Kyoto International Network. All rights reserved.